20 results on '"de Bellis, M"'
Search Results
2. Alcohol Use Disrupts Age-Appropriate Cortical Thinning in Adolescence: A Data Driven Approach
- Author
-
S.A. Brown, Susan F. Tapert, Duncan B. Clark, Rachel D. Phillips, Fiona C. Baker, Rajendra A. Morey, Kate B. Nooner, Bouchard Hc, Andrew M. Michael, Thompson Wk, Aristeidis Sotiras, De Bellis M, Viraj Adduru, Delin Sun, Bonnie J. Nagel, and David B. Goldston
- Subjects
chemistry.chemical_compound ,chemistry ,business.industry ,Cohort ,Cortical thinning ,Medicine ,Alcohol ,Age cohorts ,Age appropriate ,business ,Alcohol consumption ,Demography - Abstract
ObjectiveCortical thickness changes dramatically during development and is influenced by adolescent drinking. However, previous findings have been inconsistent and limited by region-of-interest approaches that are underpowered because they do not conform to the underlying heterogeneity from the effects of alcohol.MethodsAdolescents (n=657; 12-22 years at baseline) from the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) who endorsed little to no alcohol use at baseline were assessed with structural MRI and followed longitudinally at four yearly intervals. Seven unique spatially covarying patterns of cortical thickness were obtained from the baseline scans by applying a novel data-driven method called non-negative matrix factorization (NMF). The cortical thickness maps of all participants’ longitudinal scans were projected onto vertex-level cortical patterns to obtain participant-specific coefficients for each pattern. Linear mixed-effects models were fit to each pattern to investigate longitudinal effects of alcohol consumption on cortical thickness.ResultsIn most NMF-derived cortical thickness patterns, the longitudinal rate of decline in no/low drinkers was similar for all age cohorts, among moderate drinkers the decline was faster in the younger cohort and slower in the older cohort, among heavy drinkers the decline was fastest in the younger cohort and slowest in the older cohort (FDR corrected p-values < 0.01).ConclusionsThe NMF method can delineate spatially coordinated patterns of cortical thickness at the vertex level that are unconstrained by anatomical features. Age-appropriate cortical thinning is more rapid in younger adolescent drinkers and slower in older adolescent drinkers.
- Published
- 2021
- Full Text
- View/download PDF
3. Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments
- Author
-
Kawaguchi, Y., De Bellis, M., Panettieri, E., Duwe, G., and Vauthey, J. -N.
- Subjects
Conversion therapy ,Two-stage hepatectomy ,Gastric liver metastasis ,Liver Neoplasms ,Resection ,Prognosis ,Article ,Molecular-targeted therapy ,Chemotherapy ,Hepatectomy ,Humans ,Colorectal liver metastasis ,Colorectal Neoplasms ,Neuroendocrine liver metastasis ,Neoplasm Staging - Abstract
The benefit of resection of liver metastases depends on primary diseases. Neuroendocrine tumors are associated with favorable prognosis after resection of liver metastases. Gastric cancer has worse tumor biology, and resection of gastric liver metastases should be performed in selected patients. A multidisciplinary approach is well established for colorectal liver metastases (CLMs). Resection remains the only curative treatment of CLM. Chemotherapy and molecular-targeted therapy have improved survival in unresectable metastatic colorectal cancer. Understanding of the following two strategies, conversion therapy and two-stage hepatectomy, are important to make this patient group to be candidates for curative-intent surgery.
- Published
- 2020
4. First ever reported case of continuous spinal anesthesia da Vinci robotic partial nephrectomy
- Author
-
Gontero, P, Oderda, M, Calleris, G, Allasia, M, Agnello, M, Rampa, P, Soria, F, Lavagno, F, Mazzoli, S, De Bellis, M, Vitiello, F, Brazzi, L, Balagna, R, and Gobbi, F
- Subjects
Urology - Published
- 2022
- Full Text
- View/download PDF
5. Periendoscopic management of direct oral anticoagulants: a prospective cohort study
- Author
-
Radaelli, F, Fuccio, L, Paggi, S, Hassan, C, Repici, A, Rondonotti, E, Semeraro, R, Di Leo, M, Anderloni, A, Amato, A, Trovato, C, Bravi, I, Buda, A, de Bellis, M, D'Angelo, V, Segato, S, Tarantino, O, Musso, A, Fasoli, R, Frazzoni, L, Liverani, E, Fabbri, C, Di Giulio, E, Esposito, G, Pigò, F, Iannone, A, Dentali, F, Bowell, Group., Radaelli, Franco, Fuccio, Lorenzo, Paggi, Silvia, Hassan, Cesare, Repici, Alessandro, Rondonotti, Emanuele, Semeraro, Rossella, Di Leo, Milena, Anderloni, Andrea, Amato, Arnaldo, Trovato, Cristina, Bravi, Ivana, Buda, Andrea, de Bellis, Mario, D'Angelo, Valentina, Segato, Sergio, Tarantino, Ottaviano, Musso, Alessandro, Fasoli, Renato, Frazzoni, Leonardo, Liverani, Elisa, Fabbri, Carlo, Di Giulio, Emilio, Esposito, Gianluca, Pigò, Flavia, Iannone, Andrea, and Dentali, Francesco
- Subjects
Male ,therapeutic endoscopy ,medicine.medical_specialty ,Time Factors ,DOAC ,medicine.medical_treatment ,bleeding ,gastroenterology ,Administration, Oral ,complication ,030204 cardiovascular system & hematology ,Transient ischaemic attacks ,Lower risk ,Risk Assessment ,Endoscopy, Gastrointestinal ,Perioperative Care ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Thromboembolism ,medicine ,Humans ,Prospective Studies ,Elective surgery ,Prospective cohort study ,Gastroenterology ,Aged ,Rivaroxaban ,business.industry ,Anticoagulants ,Perioperative ,Middle Aged ,Stroke ,Treatment Outcome ,Italy ,Withholding Treatment ,Elective Surgical Procedures ,Therapeutic endoscopy ,030211 gastroenterology & hepatology ,Apixaban ,Female ,Patient Safety ,business ,Gastrointestinal Hemorrhage ,medicine.drug ,Follow-Up Studies - Abstract
Objective To assess the frequency of adverse events associated with periendoscopic management of direct oral anticoagulants (DOACs) in patients undergoing elective GI endoscopy and the efficacy and safety of the British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) recommendations (NCT 02734316). Design Consecutive patients on DOACs scheduled for elective GI endoscopy were prospectively included. The timing of DOAC interruption and resumption before and after the procedures were recorded, along with clinical and procedural data. Procedures were stratified into low-risk and high-risk for GI-related bleeding, and patients into low-risk and high-risk for thromboembolic events. Patients were followed-up for 30 days for major and clinically relevant non-major bleeding events (CRNMB), arterial and venous thromboembolism and death. Results Of 529 patients, 38% and 62% underwent high-risk and low-risk procedures, respectively. There were 45 (8.5%; 95% CI 6.3% to 11.2%) major or CRNMB events and 2 (0.4%; 95% CI 0% to 1.4%) thromboembolic events (transient ischaemic attacks). Overall, the incidence of bleeding events was 1.8% (95% CI 0.7% to 4%) and 19.3% (95% CI 14.1% to 25.4%) in low-risk and high-risk procedures, respectively. For high-risk procedures, the incidence of intraprocedural bleeding was similar in patients who interrupted anticoagulation according to BSG/ESGE guidelines or earlier (10.3%vs10.8%, p=0.99), with a trend for a lower risk as compared with those who stopped anticoagulation later (10.3%vs25%, p=0.07). The incidence of delayed bleeding appeared similar in patients who resumed anticoagulation according to BSG/ESGE guidelines or later (6.6%vs7.7%, p=0.76), but it tended to increase when DOAC was resumed earlier (14.4%vs6.6%, p=0.27). The risk of delayed major bleeding was significantly higher in patients receiving heparin bridging than in non-bridged ones (26.6%vs5.9%, p=0.017). Conclusion High-risk procedures in patients on DOACs are associated with a substantial risk of bleeding, further increased by heparin bridging. Adoption of the BSG/ESGE guidelines in periendoscopic management of DOACs seems to result in a favourable benefit/risk ratio. Trial registration number NCT 02734316; Pre-results.
- Published
- 2018
6. Random masonry as homogenized micropolar continua
- Author
-
Murrali, A., Trovalusci, Patrizia, De Bellis, M. L., and Ostoja Starzewski, M.
- Published
- 2014
7. Manuale per la gestione sostenibile ed il recupero dei residui spiaggiati di posidonia
- Author
-
Montesano F.F., Serio F., Parente A., Guido M., Lomoro A., Zini A., Santamaria P., Lapiscopia T., Romano V., and De Bellis M
- Published
- 2013
8. Linee guida operative per la gestione sostenibile dei residui spiaggiati di posidonia
- Author
-
Montesano F.F., Serio F., Parente A., Guido M., Lomoro A., Zini A., Santamaria P., Lapiscopia T., Romano V., and De Bellis M
- Published
- 2013
9. Il trattamento delle varicoflebiti: nostre esperienze
- Author
-
DONISI, MARIO, Giugliano G, Izzo F, Aprea P, Rea F, de Bellis M., Donisi, Mario, Giugliano, G, Izzo, F, Aprea, P, Rea, F, and de Bellis, M.
- Published
- 1991
10. I drenaggi della loggia tiroidea
- Author
-
DONISI, MARIO, de Bellis M, Izzo F, Aprea P, Giugliano G., Donisi, Mario, de Bellis, M, Izzo, F, Aprea, P, and Giugliano, G.
- Published
- 1990
11. The splenic-mesenteric and ileal- hepatic by- passes for the emergency revascularization of digestive organs
- Author
-
DONISI, MARIO, Ferrara R., Aprea P., De Bellis M., Lombardi D., Donisi, Mario, Ferrara, R., Aprea, P., De Bellis, M., and Lombardi, D.
- Published
- 1990
12. Comparison of laparoscopic total and partial fundoplication for gastroesophageal reflux
- Author
-
M. G. Patti, Jenny Tong, Sean J. Mulvihill, A Wang, L. W. Way, De Pinto M, Massimo Arcerito, and de Bellis M
- Subjects
Male ,medicine.medical_specialty ,Esophageal pH Monitoring ,Manometry ,Fundoplication ,Gastroenterology ,Esophagus ,Internal medicine ,medicine ,Humans ,Laparoscopy ,Partial fundoplication ,Peristalsis ,medicine.diagnostic_test ,business.industry ,Reflux ,Heartburn ,Middle Aged ,Dysphagia ,Surgery ,Regurgitation (digestion) ,Gastroesophageal Reflux ,Female ,medicine.symptom ,Esophageal pH monitoring ,business ,Deglutition Disorders - Abstract
Approximately 25% of patients with gastroesophageal reflux severe enough to be considered for surgical treatment have dysfunction of esophageal peristalsis in addition to dysfunction of the lower esophageal sphincter. A standard total (i.e., Nissen) fundoplication in these patients may be followed by dysphagia, so many experts recommend a partial fundoplication as an alternative. The goal of this study was to compare the clinical results and changes in esophageal function following laparoscopic total and partial fundoplication. Ninety-three patients with gastroesophageal reflux disease had laparoscopic antireflux operations. Total fundoplication was performed in 50 patients with normal esophageal peristalsis. Partial fundoplication was chosen for 43 patients with severe abnormalities of esophageal peristalsis. The same percentage of patients has resolution of heartburn (93%) and regurgitation (97%) after partial as compared to total fundoplication. Dysphagia developed in four patients (8%) after total fundoplication (one patient required dilatation) and in no patients after partial fundoplication. Both operations produced similar changes in lower esophageal sphincter function, but only partial fundoplication was associated with improvement in esophageal dysfunction. Esophageal acid exposure became normal in 92% of patients after total and in 91% of patients after partial fundoplication. Partial fundoplication improves lower esophageal sphincter pressure and esophageal body function and, in patients with abnormal esophageal peristalsis, it corrects reflux without producing dysphagia. Partial and total fundoplication are both indicated in patients with gastroesophageal reflux disease, and the choice of which procedure to use should be based on each patient"s specific esophageal motor function abnormalities.
- Published
- 1997
13. Communication and visiting policies in Italian intensive care units during the first COVID-19 pandemic wave and lockdown: a nationwide survey
- Author
-
Langer, Thomas, Depalo, Francesca Carmela, Forlini, Clarissa, Landini, Silvia, Mezzetti, Andrea, Previtali, Paola, Monti, Gianpaola, de Toma, Carolina, Biscardi, Davide, Giannini, Alberto, Fumagalli, Roberto, Mistraletti, Giovanni, Lissoni, Barbara, De Martini, Andrea, Mareto, Nadia, Rossitto, Concetta, Zummo, Ugo, Taverna, Martina, Machieraldo, Patrizia, Navarra, Mauro, Parlanti Garbero, Massimiliano, Scaletti, Chiara, Perno, Silvia, Amendolia, Luca, Montrucchio, Giuseppe, Veliaj, Deliana, Barbarello, Giuseppe, Alesci, Maria, Bolgiaghi, Luca, Vailati, Davide, Pezzi, Angelo, Boselli, Enrico, Piccoli, Francesca, Greco, Massimiliano, Gemma, Marco, Resta, Marco, Crotti, Stefania, Bottino, Nicola, Abruzzese, Chiara, Savioli, Monica, Migliorino, Giuseppina, Muttini, Stefano, Umbrello, Michele, Borghi, Beatrice, Greco, Stefano, Dizeo, Micaela, Bottiroli, Maurizio, Mondino, Michele Giovanni, Prosepri, Manlio, Casella, Giampaolo, Curto, Francesco, Zaniboni, Matteo, Giudici, Riccardo, Gentile, Carlo, Bombino, Michela, Rona, Roberto, Cortinovis, Barbara, Benini, Annalisa, Avalli, Leonello, Tavola, Mario, Ferrario, Matteo, Preda, Roberta, Primerano, Enzo, Russo, Gianluca, Porta, Virginia, Valdambrini, Federico, Fassini, Paola, Orando, Serena, Beck, Eduardo, Pedeferri, Matteo, Cogliati, Giacomina, Testini, Denise, Moroni, Benedetta, Codeluppi, Vito, Ruggeri, Patrizia, Milanesi, Elisa, Belliato, Mirko, Besozzi, Alessandra, Riccio, Mario, Zerbi, Silvia, Corbella, Davide, Ferri, Francesco, Grazioli, Lorenzo, Bonanomi, Ezio, Giacomini, Matteo, Sacchi, Noemi, Codognola, Cristian, Ambrosini, Alessandra, Guatteri, Luca, Subert, Matteo, Castelli, Gian Paolo, Borelli, Massimo, Venier, Erica, Dittura, Loredana, Buttera, Stefania, Bigai, Roberto, Magnoni, Sandra, Rauch, Simon, Colombo, Angelo, Fullin, Giorgio, Donolato, Caterina, Cattin, Silvia, State, Veronica, Redeghieri, Enrico, Russo, Alessandro, Pastorini, Simonetta, Allena, Sandra, Munari, Marina, Turchet, Federica, Peta, Mario, De Santis, Vincenzo, Scala, Cristina, Facondini, Francesca, Marangoni, Elisabetta, Tassinati, Tania, Zanzani, Chiara, Russo, Emanuele, Marchio, Annamaria, Barbagallo, Maria, Girardis, Massimo, Taffache, Paolo, Mordacci, Marco, Vincenzi, Matteo, Pennica, Michele, Bracciotti, Giovanna, Iori, Paola, Gambi, Davide, Cappellini, Iacopo, Vegnuti, Lara, De Luca, Alessandra, Romagnoli, Stefano, Mosti, Giamila, Carla, Rossella, Roticiani, Valeria, Pelagalli, Lorella, Fuselli, Ennio, D’Avino, Emilio, De Bellis, Massimo, Gianni, Giulia, Leonardis, Francesca, Rossi, Marzia, Lorusso, Rossana, Magnanimi, Eugenia, Martelli, Sabrina, Baisi, Floriana, Balsamo, Davide, Cotticelli, Virginia, Mattei, Alessia, Farinelli, Ivano, Riccini, Teresa, Cola, Luisanna, Jorio, Antonella, Iacobone, Emanuele, Domizi, Roberta, Pizzi, Simone, Nasso, Armando, Graziani, Romano, Monaco, Anna, Manno, Manuela, Ottelio, Carla Maria, Del Rio, Michela, Serra, Antonio, Enna, Barbara, Loddo, Francesco Marco, Galbiati, Rita, Mellea, Serena, Kimberly, Michelle Brozzi, Vissani, Matteo, Romito, Francesco Massimo, Baccari, Laura, Zarrillo, Nadia, Esposito, Clelia, Murino, Patrizia, Notaro, Salvatore, Ausiello, Carmine, Marra, Annachiara, Policastro, Carmela, Cafora, Chiara, De Benedectis, Giuseppe, Di Falco, Vincenzo, Sciddurlo, Maria, Negro, Giancarlo, Vetuschi, Paolo, Recchia, Andrea, Pasquariello, Rita, Squillace, Rosalba, Ciambrone, Antonio, Bencivenga, Carmela, Camiolo, Melania, Agozzino, Cristina, Oliveri, Francesco, Notarrigo, Tiziana, Castiglione, Giacomo, Mo, Antonella, Condorelli, Laura, Favarato, Martina, Langer, T, Depalo, F, Forlini, C, Landini, S, Mezzetti, A, Previtali, P, Monti, G, de Toma, C, Biscardi, D, Giannini, A, Fumagalli, R, Mistraletti, G, Lissoni, B, De Martini, A, Mareto, N, Rossitto, C, Zummo, U, Taverna, M, Machieraldo, P, Navarra, M, Parlanti Garbero, M, Scaletti, C, Perno, S, Amendolia, L, Montrucchio, G, Veliaj, D, Barbarello, G, Alesci, M, Bolgiaghi, L, Vailati, D, Pezzi, A, Boselli, E, Piccoli, F, Greco, M, Gemma, M, Resta, M, Crotti, S, Bottino, N, Abruzzese, C, Savioli, M, Migliorino, G, Muttini, S, Umbrello, M, Borghi, B, Greco, S, Dizeo, M, Bottiroli, M, Mondino, M, Prosepri, M, Casella, G, Curto, F, Zaniboni, M, Giudici, R, Gentile, C, Bombino, M, Rona, R, Cortinovis, B, Benini, A, Avalli, L, Tavola, M, Ferrario, M, Preda, R, Primerano, E, Russo, G, Porta, V, Valdambrini, F, Fassini, P, Orando, S, Beck, E, Pedeferri, M, Cogliati, G, Testini, D, Moroni, B, Codeluppi, V, Ruggeri, P, Milanesi, E, Belliato, M, Besozzi, A, Riccio, M, Zerbi, S, Corbella, D, Ferri, F, Grazioli, L, Bonanomi, E, Giacomini, M, Sacchi, N, Codognola, C, Ambrosini, A, Guatteri, L, Subert, M, Castelli, G, Borelli, M, Venier, E, Dittura, L, Buttera, S, Bigai, R, Magnoni, S, Rauch, S, Colombo, A, Fullin, G, Donolato, C, Cattin, S, State, V, Redeghieri, E, Russo, A, Pastorini, S, Allena, S, Munari, M, Turchet, F, Peta, M, De Santis, V, Scala, C, Facondini, F, Marangoni, E, Tassinati, T, Zanzani, C, Russo, E, Marchio, A, Barbagallo, M, Girardis, M, Taffache, P, Mordacci, M, Vincenzi, M, Pennica, M, Bracciotti, G, Iori, P, Gambi, D, Cappellini, I, Vegnuti, L, De Luca, A, Romagnoli, S, Mosti, G, Carla, R, Roticiani, V, Pelagalli, L, Fuselli, E, D’Avino, E, De Bellis, M, Gianni, G, Leonardis, F, Rossi, M, Lorusso, R, Magnanimi, E, Martelli, S, Baisi, F, Balsamo, D, Cotticelli, V, Mattei, A, Farinelli, I, Riccini, T, Cola, L, Jorio, A, Iacobone, E, Domizi, R, Pizzi, S, Nasso, A, Graziani, R, Monaco, A, Manno, M, Ottelio, C, Del Rio, M, Serra, A, Enna, B, Loddo, F, Galbiati, R, Mellea, S, Kimberly, M, Vissani, M, Romito, F, Baccari, L, Zarrillo, N, Esposito, C, Murino, P, Notaro, S, Ausiello, C, Marra, A, Policastro, C, Cafora, C, De Benedectis, G, Di Falco, V, Sciddurlo, M, Negro, G, Vetuschi, P, Recchia, A, Pasquariello, R, Squillace, R, Ciambrone, A, Bencivenga, C, Camiolo, M, Agozzino, C, Oliveri, F, Notarrigo, T, Castiglione, G, Mo, A, Condorelli, L, and Favarato, M
- Subjects
Adult ,Pandemic ,Patient-centered care ,Communication ,COVID-19 ,Professional-family relations ,Intensive Care Units ,Policy ,Anesthesiology and Pain Medicine ,Health communication ,Professional-family relation ,Surveys and Questionnaires ,Communicable Disease Control ,Intensive care units ,Pandemics ,Humans ,Intensive care unit ,Child - Abstract
Background During the first coronavirus disease 2019 (COVID-19) pandemic wave, an unprecedented number of patients with respiratory failure due to a new, highly contagious virus needed hospitalization and intensive care unit (ICU) admission. The aim of the present study was to describe the communication and visiting policies of Italian intensive care units (ICUs) during the first COVID-19 pandemic wave and national lockdown and compare these data with prepandemic conditions. Methods A national web-based survey was conducted among 290 Italian hospitals. Each ICU (active between February 24 and May 31, 2020) was encouraged to complete an individual questionnaire inquiring the hospital/ICU structure/organization, communication/visiting habits and the role of clinical psychology prior to, and during the first COVID-19 pandemic wave. Results Two hundred and nine ICUs from 154 hospitals (53% of the contacted hospitals) completed the survey (202 adult and 7 pediatric ICUs). Among adult ICUs, 60% were dedicated to COVID-19 patients, 21% were dedicated to patients without COVID-19 and 19% were dedicated to both categories (Mixed). A total of 11,102 adult patients were admitted to the participating ICUs during the study period and only approximately 6% of patients received at least one visit. Communication with family members was guaranteed daily through an increased use of electronic devices and was preferentially addressed to the same family member. Compared to the prepandemic period, clinical psychologists supported physicians more often regarding communication with family members. Fewer patients received at least one visit from family members in COVID and mixed-ICUs than in non-COVID ICUs, l (0 [0–6]%, 0 [0–4]% and 11 [2–25]%, respectively, p Conclusions Visiting policies of Italian ICUs dedicated to adult patients were markedly altered during the first COVID-19 wave. Remote communication was widely adopted as a surrogate for family meetings. New strategies to favor a family-centered approach during the current and future pandemics are warranted.
- Published
- 2022
- Full Text
- View/download PDF
14. On the Metabolically Active Form of Metaglidasen: Improved Synthesis and Investigation of Its Peculiar Activity on Peroxisome Proliferator-Activated Receptors and Skeletal Muscles
- Author
-
Vittoria Infantino, Davide Capelli, Giorgio Pochetti, Michela De Bellis, Fulvio Loiodice, Diana Conte Camerino, Antonella Liantonio, Luca Piemontese, Antonio Lavecchia, Antonio Laghezza, Roberta Montanari, Paolo Tortorella, Vito Iacobazzi, Sabata Pierno, Laghezza, A, Montanari, R, Lavecchia, Antonio, Piemontese, L, Pochetti, G, Iacobazzi, V, Infantino, V, Capelli, D, De Bellis, M, Liantonio, A, Pierno, S, Tortorella, P, Conte Camerino, D, and Loiodice, F.
- Subjects
Male ,medicine.medical_specialty ,medicine.drug_class ,Peroxisome proliferator-activated receptor ,Fibrate ,Crystallography, X-Ray ,Ligands ,PPAR ,Biochemistry ,Partial agonist ,PPAR modulator ,metaglidasen ,Internal medicine ,Drug Discovery ,medicine ,Animals ,Humans ,Hypoglycemic Agents ,PPAR alpha ,partial agonist ,Rats, Wistar ,General Pharmacology, Toxicology and Pharmaceutics ,Thiazolidinedione ,Muscle, Skeletal ,Receptor ,X-ray crystallography ,Pharmacology ,chemistry.chemical_classification ,Chemistry ,Organic Chemistry ,fibrate-like ,Antagonist ,Skeletal muscle ,Hep G2 Cells ,Molecular Docking Simulation ,PPAR gamma ,medicine.anatomical_structure ,Endocrinology ,Chloride channel ,Molecular Medicine ,X-ray structure ,Molecular recognition - Abstract
Metaglidasen is a fibrate-like drug reported as a selective modulator of peroxisome proliferator-activated receptor γ (PPARγ), able to lower plasma glucose levels in the absence of the side effects typically observed with thiazolidinedione antidiabetic agents in current use. Herein we report an improved synthesis of metaglidasen's metabolically active form halofenic acid (R)-2 and that of its enantiomer (S)-2. The activity of the two stereoisomers was carefully examined on PPARα and PPARγ subtypes. As expected, both showed partial agonist activity toward PPARγ; the investigation of PPARα activity, however, led to unexpected results. In particular, (S)-2 was found to act as a partial agonist, whereas (R)-2 behaved as an antagonist. X-ray crystallographic studies with PPARγ were carried out to gain more insight on the molecular-level interactions and to propose a binding mode. Given the adverse effects provoked by fibrate drugs on skeletal muscle function, we also investigated the capacity of (R)-2 and (S)-2 to block conductance of the skeletal muscle membrane chloride channel. The results showed a more beneficial profile for (R)-2, the activity of which on skeletal muscle function, however, should not be overlooked in the ongoing clinical trials studying its long-term effects.
- Published
- 2015
- Full Text
- View/download PDF
15. A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)
- Author
-
Gerardo Rosati, Francesco Bianco, Antonella Petrillo, Chiara Carlomagno, Guglielmo Nasti, Vincenzo Rosario Iaffaioli, Alessandra Leone, Pasquale Aprea, Vincenza Granata, Carmela Romano, Ciro Gallo, Elisabetta de Lutio di Castelguidone, Paolo Delrio, Piera Maiolino, Gerardo Botti, Mario De Bellis, Elena Di Gennaro, Luigi Aloj, Secondo Lastoria, Orlando Catalano, Maria Carmela Piccirillo, Fabiana Tatangelo, Corradina Caracò, Alessandro Bertolini, Alfredo Budillon, Francesco Izzo, Biagio Pecori, Antonio Avallone, Giovanni Maria Romano, Ernesta Cavalcanti, Gennaro Daniele, Francesco Perrone, Aloj, Luigi [0000-0002-7452-4961], Apollo - University of Cambridge Repository, Avallone, A., Piccirillo, M. C., Aloj, L., Nasti, G., Delrio, P., Izzo, F., Di Gennaro, E., Tatangelo, F., Granata, V., Cavalcanti, E., Maiolino, P., Bianco, F., Aprea, P., De Bellis, M., Pecori, B., Rosati, G., Carlomagno, C., Bertolini, A., Gallo, C., Romano, C., Leone, A., Caraco, C., de Lutio di Castelguidone, E., Daniele, G., Catalano, O., Botti, G., Petrillo, A., Romano, G. M., Iaffaioli, V. R., Lastoria, S., Perrone, F., Budillon, A., Avallone, Antonio, Piccirillo, Maria Carmela, Aloj, Luigi, Nasti, Guglielmo, Delrio, Paolo, Izzo, Francesco, Di Gennaro, Elena, Tatangelo, Fabiana, Granata, Vincenza, Cavalcanti, Ernesta, Maiolino, Piera, Bianco, Francesco, Aprea, Pasquale, De Bellis, Mario, Pecori, Biagio, Rosati, Gerardo, Carlomagno, Chiara, Bertolini, Alessandro, Gallo, Ciro, Romano, Carmela, Leone, Alessandra, Caracò, Corradina, de Lutio di Castelguidone, Elisabetta, Daniele, Gennaro, Catalano, Orlando, Botti, Gerardo, Petrillo, Antonella, Romano, Giovanni M., Iaffaioli, Vincenzo R., Lastoria, Secondo, Perrone, Francesco, and Budillon, Alfredo
- Subjects
0301 basic medicine ,Oncology ,Male ,Vascular Endothelial Growth Factor A ,Cancer Research ,Organoplatinum Compounds ,Colorectal cancer ,Leucovorin ,Phases of clinical research ,Colorectal Neoplasm ,Study Protocol ,0302 clinical medicine ,FOLFOX ,Antineoplastic Combined Chemotherapy Protocols ,Clinical endpoint ,FDG-PET ,Antibodies, Monoclonal ,Middle Aged ,Prognosis ,Oxaliplatin ,Bevacizumab ,030220 oncology & carcinogenesis ,Female ,Fluorouracil ,Colorectal Neoplasms ,medicine.drug ,Human ,Adult ,medicine.medical_specialty ,Prognosi ,Antibodies, Monoclonal, Humanized ,Biomarkers for anti-angiogenic therapy ,Disease-Free Survival ,03 medical and health sciences ,Internal medicine ,medicine ,Genetics ,Humans ,Aged ,Antineoplastic Combined Chemotherapy Protocol ,business.industry ,Organoplatinum Compound ,medicine.disease ,Clinical trial ,Regimen ,030104 developmental biology ,Vessel normalization ,business - Abstract
BACKGROUND: Despite the improvements in diagnosis and treatment, colorectal cancer (CRC) is the second cause of cancer deaths in both sexes. Therefore, research in this field remains of great interest. The approval of bevacizumab, a humanized anti-vascular endothelial growth factor (VEGF) monoclonal antibody, in combination with a fluoropyrimidine-based chemotherapy in the treatment of metastatic CRC has changed the oncology practice in this disease. However, the efficacy of bevacizumab-based treatment, has thus far been rather modest. Efforts are ongoing to understand the better way to combine bevacizumab and chemotherapy, and to identify valid predictive biomarkers of benefit to avoid unnecessary and costly therapy to nonresponder patients. The BRANCH study in high-risk locally advanced rectal cancer patients showed that varying bevacizumab schedule may impact on the feasibility and efficacy of chemo-radiotherapy. METHODS/DESIGN: OBELICS is a multicentre, open-label, randomised phase 3 trial comparing in mCRC patients two treatment arms (1:1): standard concomitant administration of bevacizumab with chemotherapy (mFOLFOX/OXXEL regimen) vs experimental sequential bevacizumab given 4 days before chemotherapy, as first or second treatment line. Primary end point is the objective response rate (ORR) measured according to RECIST criteria. A sample size of 230 patients was calculated allowing reliable assessment in all plausible first-second line case-mix conditions, with a 80% statistical power and 2-sided alpha error of 0.05. Secondary endpoints are progression free-survival (PFS), overall survival (OS), toxicity and quality of life. The evaluation of the potential predictive role of several circulating biomarkers (circulating endothelial cells and progenitors, VEGF and VEGF-R SNPs, cytokines, microRNAs, free circulating DNA) as well as the value of the early [(18)F]-Fluorodeoxyglucose positron emission tomography (FDG-PET) response, are the objectives of the traslational project. DISCUSSION: Overall this study could optimize bevacizumab scheduling in combination with chemotherapy in mCRC patients. Moreover, correlative studies could improve the knowledge of the mechanisms by which bevacizumab enhance chemotherapy effect and could identify early predictors of response. EudraCT Number: 2011-004997-27 TRIAL REGISTRATION: ClinicalTrials.gove number, NCT01718873.
- Published
- 2016
16. Immunohistochemical and histomorphometric study of human uvula innervation: a comparative analysis of non-snorers versus apneic snorers
- Author
-
Guglielmo Nicoletti, Fabio Pagni, Claudio Vicini, Mauro De Bellis, Sonia Gorla, Susanna Ronchi, Camillo Di Bella, Giuseppe Limonta, Monica Cucci, De Bellis, M, Pagni, F, Ronchi, S, Limonta, G, Gorla, S, Nicoletti, G, Cucci, M, Di Bella, C, and Vicini, C
- Subjects
Adult ,Male ,medicine.medical_specialty ,Sleep Apnea ,Palatopharyngeus muscle ,Biopsy ,Polysomnography ,medicine.medical_treatment ,Neural deficit ,Snorers ,Uvulas ,Aged ,Body Mass Index ,Female ,Humans ,Middle Aged ,Nerve Fibers ,Pharyngeal Muscles ,Reference Values ,Sleep Apnea, Obstructive ,Snoring ,Uvula ,Young Adult ,Otorhinolaryngology2734 Pathology and Forensic Medicine ,Neurology (clinical) ,Medicine (all) ,Motor nerve ,Economica ,Ptosis ,Head and neck pasthology ,Medicine ,medicine.diagnostic_test ,Obstructive ,business.industry ,Uvulopalatopharyngoplasty ,medicine.disease ,Surgery ,Obstructive sleep apnea ,Otorhinolaryngology ,Inclusion and exclusion criteria ,medicine.symptom ,business - Abstract
Objective: The objective of this study was to verify a possible correlation between the etiology of uvulopalatal ptosis and decrease in palatopharyngeal muscle tone, due to a reduction of the number of nerve fibers in surgical specimens obtained from snoring patients. Design/setting of the study: We have designed a comparative retrospective, case-control, double-blind, immunohistochemical and histomorphometric study of human uvula innervation in 51 apneic snoring patients who underwent uvulopalatopharyngoplasty (UPPP) and 47 normal subjects collected in a 5-year-long period in the Departments of Otolaryngology of Desio and Forlì Hospital, Italy. Patients: Case study was chosen in patients who underwent UPPP, variably associated with other disobstructive surgical procedures for treatment of obstructive sleep apnea syndrome, classified according to current clinical, polysomnographic, endoscopic, and imaging criteria. Control subjects were recruited at the Institute of Legal Medicine, University of Milan, according to strong inclusion and exclusion criteria. The main outcome measure of the study was the number of nerve fibers in the patients' uvula evaluated histologically and repeated two times by two different people, in all the areas of the specimens. Finally, we correlated the area of the histological section with the number of fibers contained therein. Results: The number of nerve fibers varied from a minimum of 58 to a maximum of 163 in normal subjects. In the snoring patient population, the number of nerve fibers varied from a minimum of 22 to a maximum of 126 (statistically significant difference, p < 0.0001). In conclusion, our results direct toward a clear neurogenetic predisposition to uvulopalatal ptosis, marked ab initio by a lower set of motor nerve fibers, which may be the initial stage of another subsequent morphological and functional abnormality. © 2011 Springer-Verlag.
- Published
- 2011
- Full Text
- View/download PDF
17. Risk factors for stent-related adverse events in patients with obstructive colorectal cancer: are we missing something?
- Author
-
Lorenzo Fuccio, Mario De Bellis, Vincenzo Cennamo, Fuccio L, Cennamo V, and de Bellis M
- Subjects
Oncology ,medicine.medical_specialty ,Colorectal cancer ,Colon ,medicine.medical_treatment ,MEDLINE ,Risk Assessment ,Colonic Diseases ,Text mining ,Internal medicine ,Medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Intestinal obstruction surgery ,In patient ,Adverse effect ,Intraoperative Complications ,COLORECTAL CANCER ,business.industry ,Gastroenterology ,Stent ,medicine.disease ,Intestinal Perforation ,SEMS ,Stents ,business ,Intestinal Obstruction - Published
- 2014
18. Comment on 'Self-expandable metal stents for malignant colonic obstruction: Data from a retrospective regional SIED-AIGO study' by R. Di Mitri, F. Mocciaro, M. Traina et al. [Digestive and Liver Disease 2014;46:279–82]
- Author
-
Vincenzo Cennamo, Mario De Bellis, Lorenzo Fuccio, Fuccio L, Cennamo V, and de Bellis M
- Subjects
COLORECTAL CANCER ,medicine.medical_specialty ,Hepatology ,business.industry ,Colorectal cancer ,Gastroenterology ,medicine.disease ,Self Expandable Metal Stents ,Colonic obstruction ,Liver disease ,Internal medicine ,SELF-EXPANDING METAL STENTS ,Medicine ,Poor performance status ,business - Abstract
arct S [1] Fuccio L. Comment on “Self-expandable metal stents for malignant colonic obstruction: data from a retrospective regional SIED-AIGO study” by R. Di Mitri, F. Mocciaro, M. Traina et al. [Digestive and Liver Disease 2014;46:279–82]. Digestive and Liver Disease 2014;46:859–60. [2] Di Mitri R, Mocciaro F, Traina M, et al. Self-expandable stents for malignant colonic obstruction: data from a retrospective regional SIED-AIGO study. Digestive and Liver Disease 2014;46:279–82. [3] Sanoff HK. Therapy for metastatic colorectal cancer in elderly patients and those with a poor performance status; 2014. Uptodate.com. our ts: 7.
- Published
- 2014
- Full Text
- View/download PDF
19. Endoscopic Palliation in Patients With Incurable Malignant Colorectal Obstruction by Means of Self-expanding Metal Stent
- Author
-
Gianpiero Manes, Pietro Occhipinti, Enzo Masci, Benedetto Mangiavillano, Giovanni Battista Rossi, Sandro Ardizzone, Vincenzo Cennamo, Alessandra Carlino, Alessandro Repici, Lorenzo Fuccio, Mario De Bellis, Manes G, de Bellis M, Fuccio L, Repici A, Masci E, Ardizzone S, Mangiavillano B, Carlino A, Rossi GB, Occhipinti P, and Cennamo V.
- Subjects
Adult ,Male ,medicine.medical_specialty ,Palliative care ,Bevacizumab ,medicine.medical_treatment ,BEVACIZUMAB ,Perforation (oil well) ,COLON CANCER ,Prosthesis Design ,Young Adult ,medicine ,Humans ,Survival rate ,Aged ,Retrospective Studies ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Palliative Care ,Colostomy ,Stent ,Endoscopy ,Retrospective cohort study ,Middle Aged ,STENTING ,Surgery ,Survival Rate ,Treatment Outcome ,Metals ,Female ,Stents ,SEMS ,OBSTRUCTION ,Colorectal Neoplasms ,business ,Intestinal Obstruction ,medicine.drug - Abstract
OBJECTIVES: To evaluate the short- and long-term efficacy of self-expanding metal stents (SEMSs) in patients with colorectal obstruction and incurable cancer and the related factors that affect outcomes. DESIGN: Retrospective analysis of SEMS placement for incurable colorectal obstruction in a 3-year period. SETTING: Five tertiary care endoscopic centers. PATIENTS AND INTERVENTION: Consecutive patients (N = 201) undergoing stenting for incurable malignant obstruction. MAIN OUTCOME MEASUREMENTS: Clinical and technical success of stenting, complications rate, and factors affecting outcomes. RESULTS: Technical success was achieved in 184 of 201 patients (91.5%) and clinical success occurred in 165 of 184 patients (89.7%; 82.1% of 201 patients). Technical and clinical failures were more frequent in extrinsic and long colorectal stenoses. Overall, 165 patients had normal bowel movements during follow-up (mean [SD], 115.5 [100.3] days; range, 1-500 days), 15 developed complications, 127 had a functioning SEMS at the time of death, and 23 were alive at completion of the study. Twenty-four (11.9%) major complications occurred: 11 migrations, 12 perforations, and 1 reobstruction. Migration of SEMSs was associated with stent diameter less than 25 mm. Bevacizumab therapy increased the risk of perforation by 19.6-fold. Karnofsky performance status of 50 or less was associated with shorter survival and a 3.7-fold higher risk of death within 6 months after the stent was placed. CONCLUSIONS: The use of SEMSs is safe and effective for palliation of incurable malignant colonic obstruction; approximately 75% of patients with SEMSs are able to avoid colostomy.
- Published
- 2011
- Full Text
- View/download PDF
20. On the cosserat-cauchy homogenization procedure for heterogeneous periodic media
- Author
-
Addessi, D., maria laura de bellis, Sacco, E., Addessi, D., DE BELLIS, MARIA LAURA, Sacco, E., Eugenio Oñate, Xavier Oliver, Antonio Huerta, and De Bellis, M. L.
- Subjects
Heterogeneous periodic materials ,Cosserat continuum ,Kinematic map ,Perturbation displacements ,Constitutive identification ,Constitutive identification, Cosserat continuum, Heterogeneous periodic materials, Kinematic map, Perturbation displacements ,Heterogeneous periodic material - Abstract
In the present paper the homogenization problem of periodic composites is investigated, in the case of a Cosserat continuum at the macro-level and a Cauchy continuum at the micro-level. In the framework of a strain-driven approach, the two levels are linked by a kinematic map based on a third order polynomial expansion. The determination of the displacement perturbation fields in the Unit Cell (UC), arising when second or third order polynomial boundary conditions are imposed, is investigated. A new micromechanical approach, based on the decomposition of the perturbation fields in terms of functions which depend on the macroscopic strain components, is proposed. The identification of the linear elastic 2D Cosserat constitutive parameters is performed, by using a Hill-Mandel-type macrohomogeneity condition. The influence of the selection of the UC is analyzed and some critical issues are outlined. Numerical examples referred to a specific composite with cubic symmetry are shown.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.